T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
East-West Bancorp
EWBC
$18.5B
| $183M | 0.02% |
2,820,075
-102,074
| -3% | -$7.33M |
|
|
SIVB
502
DELISTED
SVB Financial Group
SIVB
| $182M | 0.02% |
461,813
+47,156
| +11% | +$22.2M |
|
503
McKesson
MCK
$102B
| $182M | 0.02% |
558,719
-55,076
| -9% | -$17.6M |
|
504
Nomad Foods
NOMD
$1.59B
| $182M | 0.02% |
9,080,671
+299,689
| +3% | +$6.06M |
|
505
Marathon Petroleum
MPC
$97.8B
| $181M | 0.02% |
2,197,200
-46,140
| -2% | -$4.31M |
|
506
Xencor
XNCR
$1.72B
| $181M | 0.02% |
6,599,071
+744,569
| +13% | +$18.4M |
|
507
MGE Energy Inc
MGEE
$3.07B
| $180M | 0.02% |
2,314,802
+191,995
| +9% | +$15.3M |
|
508
Middleby
MIDD
$5.38B
| $179M | 0.02% |
1,429,653
-76,024
| -5% | -$11M |
|
509
Helios Technologies
HLIO
$2.66B
| $179M | 0.02% |
2,702,808
+15,004
| +0.6% | +$1.04M |
|
510
ResMed
RMD
$32.8B
| $178M | 0.02% |
849,640
-74,498
| -8% | -$15.9M |
|
511
Etsy
ETSY
$7.31B
| $177M | 0.02% |
2,421,808
-2,212,397
| -48% | -$202M |
|
512
Phreesia
PHR
$758M
| $176M | 0.02% |
7,024,064
-1,112,793
| -14% | -$24.5M |
|
513
Atmos Energy
ATO
$28.7B
| $176M | 0.02% |
1,566,135
-215,812
| -12% | -$24.7M |
|
514
Liberty Energy
LBRT
$3.52B
| $173M | 0.02% |
13,553,932
+734,764
| +6% | +$11.5M |
|
515
American Homes 4 Rent
AMH
$12.2B
| $173M | 0.02% |
4,876,063
+4,788,904
| +5,494% | +$181M |
|
516
3M
MMM
$94.8B
| $173M | 0.02% |
1,595,825
-150,336
| -9% | -$18.2M |
|
517
Cavco Industries
CVCO
$4.6B
| $172M | 0.02% |
878,474
-11,820
| -1% | -$2.63M |
|
518
Bath & Body Works
BBWI
$3.65B
| $171M | 0.02% |
6,364,253
+484,674
| +8% | +$21M |
|
|
BNY
519
Bank of New York Mellon
BNY
$111B
| $169M | 0.02% |
4,058,803
-3,059,135
| -43% | -$136M |
|
520
ICICI Bank
IBN
$107B
| $169M | 0.02% |
9,499,877
-3,358,218
| -26% | -$62.8M |
|
521
Monro
MNRO
$359M
| $168M | 0.02% |
3,918,309
+25,395
| +0.7% | +$1.14M |
|
522
Expro Ltd
XPRO
$2.07B
| $167M | 0.02% |
14,537,753
+8,531
| +0.1% | +$122K |
|
|
CERE
523
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $166M | 0.02% |
6,295,908
-182,102
| -3% | -$5.17M |
|
524
BellRing Brands
BRBR
$1.26B
| $166M | 0.02% |
6,684,211
+97,600
| +1% | +$2.39M |
|
525
IBM
IBM
$222B
| $165M | 0.02% |
1,171,535
-120,571
| -9% | -$16.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.